Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study

Alex Harrison, Linda Scobie, Claire Crossan, Robb Parry, Paul Johnston, Jon Stratton, Steve Dickinson, Vic Ellis, Jeremy G. Hunter, Oliver R. Prescott, Richie Madden, Nan X. Lin, William E. Henley, Richard P. Bendall, Harry Dalton

Research output: Contribution to journalArticle

Abstract

Locally acquired HEV infection is increasingly recognized in developed countries. Anti-HEV IgG seroprevalence has been shown to be high in haemodialysis patients in a number of previous studies, employing assays of uncertain sensitivity. The aim of this study was to investigate anti-HEV IgG seroprevalence in recipients of haemodialysis and renal transplants compared to a control group using a validated, highly sensitive assay.
Original languageEnglish
Pages (from-to)266-271
Number of pages6
JournalJournal of Medical Virology
Volume85
Issue number2
DOIs
Publication statusPublished - Feb 2013

Keywords

  • hepatitis E
  • seroprevalence
  • renal transplants
  • haemodialysis patients

Fingerprint Dive into the research topics of 'Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study'. Together they form a unique fingerprint.

  • Cite this

    Harrison, A., Scobie, L., Crossan, C., Parry, R., Johnston, P., Stratton, J., Dickinson, S., Ellis, V., Hunter, J. G., Prescott, O. R., Madden, R., Lin, N. X., Henley, W. E., Bendall, R. P., & Dalton, H. (2013). Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. Journal of Medical Virology, 85(2), 266-271. https://doi.org/10.1002/jmv.23463